Current Report Filing (8-k)
May 20 2019 - 4:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): May 14, 2019
Health
Insurance Innovations, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35811
|
|
46-1282634
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
15438
N. Florida Avenue, Suite 201
Tampa,
Florida
|
|
33613
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (813) 397-1187
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.07. Submission of Matters to a Vote of Security Holders.
On
May 14, 2019, Health Insurance Innovations, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual
Meeting”). The Company previously filed with the SEC its Definitive Proxy Statement and related materials pertaining to
the Annual Meeting on April 18, 2019. On the record date of April 12, 2019 there were 11,532,687 shares of the Company’s
Class A common stock and 2,416,667 shares of the Company’s Class B common stock outstanding and eligible to vote.
At the Annual Meeting, the stockholders: (i) elected the eight persons identified below to serve as directors of the Company to
hold office until the Company’s 2020 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
(ii) approved, on an advisory basis, the compensation of the Company’s Named Executive Officers; and (iii) granted advisory
approval on a one-year frequency for holding future advisory votes on the compensation of the Company’s Named Executive
Officers.
Proposal
1: Election of Directors
The
final results of stockholder voting on the election of directors were as follows:
Name
|
|
Votes For
|
|
Votes Withheld
|
|
Broker Non-Votes
|
Paul E. Avery
|
|
9,230,196
|
|
105,099
|
|
0
|
|
|
|
|
|
|
|
Anthony J. Barkett
|
|
9,079,617
|
|
255,678
|
|
0
|
|
|
|
|
|
|
|
Ellen M. Duffield
|
|
9,229,072
|
|
106,223
|
|
0
|
|
|
|
|
|
|
|
John A. Fichthorn
|
|
9,230,205
|
|
105,090
|
|
0
|
|
|
|
|
|
|
|
Paul G. Gabos
|
|
9,079,575
|
|
255,720
|
|
0
|
|
|
|
|
|
|
|
Robert S. Murley
|
|
9,083,492
|
|
251,803
|
|
0
|
|
|
|
|
|
|
|
Peggy B. Scott
|
|
9,229,069
|
|
106,226
|
|
0
|
|
|
|
|
|
|
|
Gavin D. Southwell
|
|
9,230,020
|
|
105,275
|
|
0
|
Proposal
2: Approval of, on an Advisory Basis, Named Executive Officer Compensation
The
final results of stockholder voting on the approval of, on an advisory basis, the compensation of the Company’s Named Executive
Officers were as follows:
Votes
For
|
|
Votes
Against
|
|
Votes
Abstain
|
|
Broker
Non-Votes
|
9,126,880
|
|
200,193
|
|
8,221
|
|
0
|
Proposal
3: Nonbinding Advisory Vote on Frequency of Future Advisory Votes on Named Executive Officer Compensation
The
final results of stockholder voting on the frequency of future advisory votes on the compensation of the Company’s Named
Executive Officers were as follows:
One
Year
|
|
Two
Years
|
|
Three
Years
|
|
Votes
Abstain
|
|
Broker
Non-Votes
|
9,294,453
|
|
10,098
|
|
15,879
|
|
14,
863
|
|
0
|
Following
the Annual Meeting, the Board of Directors of the Company considered the voting results on Proposal 3, the nonbinding advisory
vote on the frequency of future advisory votes on Named Executive Officer compensation. Based on all of the factors taken into
consideration, the Company has decided that it will hold an advisory vote on the compensation of its Named Executive Officers
with a frequency of one year.
The
stockholders did not vote on any other matters at the Annual Meeting.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTH
INSURANCE INNOVATIONS, INC.
|
|
|
|
|
By:
|
/s/
Michael D. Hershberger
|
|
Name:
|
Michael
D. Hershberger
|
|
Title:
|
Chief
Financial Officer
|
Date:
May 20, 2019
Health Insurance Innovat... (NASDAQ:HIIQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Historical Stock Chart
From Apr 2023 to Apr 2024